SEI Investments’s Arcus Biosciences RCUS Stock Holding History

SEI Investments’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$435K	Buy	14,111 +3,816	+37%	+$94.3K	﹤0.01%	2698
2026 Q1	$222K	Hold	10,295	–	–	﹤0.01%	2936
2025 Q4	$245K	Buy	+10,295	New	+$210K	﹤0.01%	2819
2022 Q2	–	Sell	-45,343	Closed	-$1.43M	–	2704
2022 Q1	$1.43M	Sell	45,343 -4,816	-10%	-$161K	﹤0.01%	1676
2021 Q4	$2.03M	Buy	+50,159	New	+$1.95M	﹤0.01%	1581
2020 Q3	–	Sell	-11,938	Closed	-$295K	–	2489
2020 Q2	$295K	Buy	+11,938	New	+$322K	﹤0.01%	2091

Other funds holding RCUS

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SEI Investments's RCUS Position: Q2 2026 in Review

SEI Investments increased its Arcus Biosciences (RCUS) stake by 37% in Q2 2026, buying an estimated $94.3K and bringing the position to 14,111 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

SEI Investments first reported a position in RCUS in Q2 2020 and has held it in 6 quarters since. The position peaked at $2.03M in Q4 2021. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

SEI Investments held 14,111 shares of Arcus Biosciences worth $435K as of Q2 2026.
SEI Investments bought 3,816 Arcus Biosciences shares in Q2 2026, an estimated $94.3K.
Arcus Biosciences made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2698 holding.
SEI Investments first reported a position in Arcus Biosciences in Q2 2020 and has held it in 6 quarters since.
SEI Investments's Arcus Biosciences position peaked at $2.03M in Q4 2021.
231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.